PRICE T ROWE ASSOCIATES INC /MD/ - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$30,380
-24.2%
301,237
+2.1%
0.00%
-33.3%
Q2 2023$40,077
+66.2%
294,914
+27.0%
0.01%
+50.0%
Q1 2023$24,114
-0.3%
232,167
-14.9%
0.00%0.0%
Q4 2022$24,178
-99.9%
272,770
+0.1%
0.00%0.0%
Q3 2022$21,844,000
-15.7%
272,463
+0.7%
0.00%
+33.3%
Q2 2022$25,908,000
-35.0%
270,548
+0.8%
0.00%
-25.0%
Q1 2022$39,865,000
+5.3%
268,361
+0.5%
0.00%
+33.3%
Q4 2021$37,842,000
+17.2%
266,942
+8.2%
0.00%0.0%
Q3 2021$32,278,000
+7.1%
246,716
+12.5%
0.00%0.0%
Q2 2021$30,136,000
+1926.6%
219,279
+1826.4%
0.00%
Q1 2021$1,487,000
-8.3%
11,383
-21.4%
0.00%
Q4 2020$1,622,000
+41.3%
14,485
-0.7%
0.00%
Q3 2020$1,148,000
+3.5%
14,588
-5.3%
0.00%
Q2 2020$1,109,000
+26.3%
15,410
+0.5%
0.00%
Q1 2020$878,000
-48.2%
15,339
+1.1%
0.00%
Q4 2019$1,696,000
+25.1%
15,169
+7.6%
0.00%
Q3 2019$1,356,000
+13.5%
14,099
+1.0%
0.00%
Q2 2019$1,195,000
+3.6%
13,961
+0.7%
0.00%
Q1 2019$1,153,000
+30.3%
13,860
+0.5%
0.00%
Q4 2018$885,000
-4.1%
13,790
+18.4%
0.00%
Q3 2018$923,000
+7.7%
11,648
-0.5%
0.00%
Q2 2018$857,000
+16.0%
11,703
+0.2%
0.00%
Q1 2018$739,000
+24.8%
11,674
+0.5%
0.00%
Q4 2017$592,000
-3.0%
11,620
-0.1%
0.00%
Q3 2017$610,000
+3.0%
11,6300.0%0.00%
Q2 2017$592,000
+10.7%
11,630
-3.4%
0.00%
Q1 2017$535,000
+0.6%
12,0400.0%0.00%
Q4 2016$532,000
-10.3%
12,040
-18.6%
0.00%
Q3 2016$593,000
+3.5%
14,800
+23.3%
0.00%
Q2 2016$573,000
+13.9%
12,0000.0%0.00%
Q1 2016$503,000
-1.8%
12,000
+3.3%
0.00%
Q4 2015$512,000
+11.1%
11,620
+20.4%
0.00%
Q3 2015$461,000
-18.0%
9,6500.0%0.00%
Q2 2015$562,000
+15.4%
9,6500.0%0.00%
Q1 2015$487,000
+12.2%
9,6500.0%0.00%
Q4 2014$434,000
+21.9%
9,6500.0%0.00%
Q3 2014$356,000
-16.4%
9,6500.0%0.00%
Q2 2014$426,000
+1.7%
9,6500.0%0.00%
Q1 2014$419,000
-48.9%
9,650
-50.0%
0.00%
Q4 2013$820,000
+150.0%
19,300
+100.0%
0.00%
Q3 2013$328,000
-42.7%
9,650
-47.3%
0.00%
Q2 2013$572,00018,3000.00%
Other shareholders
CONMED CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders